Variant PIK3R1 Hypermorphic Mutation and Clinical Phenotypes in a Family with Short Statures, Mild Immunodeficiency and Lymphoma
暂无分享,去创建一个
A. Rösen‐Wolff | F. Hauck | I. Bilic | T. Hirschmugl | J. Roesler | K. Boztug | T. Magg | H. Luksch | A. Krolo | M. Laaß
[1] Bodo Grimbacher,et al. Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study , 2017, The Journal of allergy and clinical immunology.
[2] T. Molina,et al. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study. , 2016, The Journal of allergy and clinical immunology.
[3] S. Petrovski,et al. Dominant Splice Site Mutations in PIK3R1 Cause Hyper IgM Syndrome, Lymphadenopathy and Short Stature , 2016, Journal of Clinical Immunology.
[4] C. Fagour,et al. Clinical reappraisal of SHORT syndrome with PIK3R1 mutations: toward recommendation for molecular testing and management , 2016, Clinical genetics.
[5] V. Lougaris,et al. Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype. , 2015, Clinical immunology.
[6] J. Hughes,et al. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K , 2014, The Journal of experimental medicine.
[7] P. Bauer,et al. PIK3R1 mutations in SHORT syndrome , 2014, Clinical genetics.
[8] J. B. Oliveira,et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency , 2013, Nature Immunology.
[9] Arndt Borkhardt,et al. Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27 , 2013, Haematologica.
[10] W. Klapper,et al. De novo PIK3R1 gain-of-function with recurrent sinopulmonary infections, long-lasting chronic CMV-lymphadenitis and microcephaly. , 2016, Clinical immunology.
[11] Patrick Nitschke,et al. A human immunodeficiency caused by mutations in the PIK3R1 gene. , 2015, The Journal of clinical investigation.